Updated 20:04 GMT, 28 Oct 2026 SPX 7,744.01 +0.28% NDX 29,813.16 +0.55% VIX 16.87 -3.71% GOLD 4,077.30 +0.07% CL 102.52 +2.62% BTC 81,597.92 +0.98%
NAS100 29,813 +0.55% S&P 7,744 +0.28% GOLD $4,077 +0.07% BTC $81,598 +0.98% VIX 16.87 −3.71% latest tape · as of 20:04 UTC
The Screen · Financials

ProShares UltraShort MSCI Emerging Markets -2x Shares

EEV · NYSE ARCA · USD

The index is designed to measure the performance of large and mid-capitalization companies across 24 emerging market countries.

FAIL · Does not pass the screen
12.29 USD

Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 5 days ago

Screened 2026-10-23 · the tape above runs as of 20:04 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price12.29 USD at the 23 Oct 2026 close
  • Ethical screenDoes not pass
  • Last reviewed23 Oct 2026 (5 days ago)

A summary of the dated readings below, not a live quote and not advice.

PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y

What this means: price 12.29 against the desk's fair-value range, over the last year.

Current read
Markup ?
Screened · screened 2026-10-23
  • Trend Markup
  • Insiders no filings inside 60 days, left as found
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price12.29 USD
Ethical score30.0/100
Our investment reviews on this name
2026-10-11Read Markup10.18+20.7% to today ✓Distribution gives way to Markup after an 11% slide in 14 weeks
2026-07-02Read Distribution11.46+7.3% to today First review on file: Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its markup label.

ProShares UltraShort MSCI Emerging Markets -2x Shares holds its Markup at $12.29. The statistical read favours the buyers, held for 38 days.

As held on the ledger · 2026-10-23
PhaseMarkup
Quantitative stateThe statistical read favours the buyers, held for 38 days
Price at the screen$12.29
ValuationN/A trailing · N/A forward price to earnings
Values screenFAIL · score 30.0
The Workings

Five Screens, Shown in Full

Does not pass. Financial sector: Financial

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Financial sector: Financial Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

ProShares UltraShort MSCI Emerging Markets -2x Shares does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-10-27. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when EEV's ethical verdict changes

Today EEV does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

Where & How to Trade

EEV trades on NYSE ARCA. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-10-25 Markup $10.94 +7.5% Entry 8

The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 10%.

2026-10-11 Markup · changed $10.18 +0.0% Entry 7

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 10%.

2026-10-02 Distribution $10.18 -11.1% Entry 6

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 11.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 10%.

2026-08-27 Distribution $11.46 +0.0% Entry 5

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 10%.

2026-07-27 Distribution $11.46 +0.0% Entry 4

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 10%.

2026-07-18 Distribution $11.46 +0.0% Entry 3

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 51%. Our forward projection puts the odds of a 10% gain over the next month near 10%.

2026-07-03 Distribution $11.46 +0.0% Entry 2

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.

2026-07-02 Distribution $11.46 Entry 1

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Political Ledger · Congressional Disclosures
Disclosures naming EEV
DatePoliticianPartyTypeAmount
2026-05-15 Ro Khanna Democrat buy 1K–15K
What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $11.66 +6.7% · $1,067 +6.7%
2 months $14.79 -15.9% · $841 -15.9%
3 months $17.19 -27.6% $0.02 $725 -27.5%
6 months $19.14 -35.0% $0.30 $665 -33.5%
1 year $25.32 -50.9% $0.81 $523 -47.7%
2 years $33.43 -62.8% $2.30 $441 -55.9%
3 years $37.20 -66.6% $3.76 $435 -56.5%
5 years $25.83 -51.9% $4.07 $639 -36.1%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever EEV does next, these words stay.

ProShares UltraShort MSCI Emerging Markets -2x Shares · EEV · Markup · $12.29
Recorded 2026-10-23 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.